Prothya Biosolutions Belgium
0462.229.645 · rovalta.com · 25/09/2026
Prothya Biosolutions Belgium
Financial year 2026 · Closed on 31/03/2026
Overview
Identity
Source · BCE/KBOProthya Biosolutions Belgium is a Private limited company incorporated in 1997. Its main activity is: Manufacture of basic pharmaceutical products. Its registered office is in Bruxelles. It employs on average 349,0 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0462.229.645
- Incorporation
- 24/12/1997
- Legal form
- Private limited company
- Registered office
- Avenue de Tyras 109
1120 Bruxelles · BruxellesSee on map - Contributed capital
- 1 412 095,45 €
- Latest accounts
- 31/03/2026
- Average workforce
- 349,0 ETP
Joint committees (3)
- 207.00
- 330
- 330.04
Financials
Source · NBB, 27 filingsTrend over 5 financial years
| 2026 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Revenue | 109,1 M € | -6.6% | 116,8 M € | -22.3% | 150,4 M € | +22.6% | 122,7 M € | +44.4% | 84,9 M € |
| EBITDA | 15,5 M € | +49.3% | 10,4 M € | +12.5% | 9,2 M € | -38.1% | 14,9 M € | +90.0% | 7,9 M € |
| Operating result | 6,6 M € | +113% | 3,1 M € | +510% | 503 k € | -93.9% | 8,2 M € | +136% | 3,5 M € |
| Net result | -620,4 k € | +58.9% | -1,5 M € | +0.8% | -1,5 M € | -130% | 5,2 M € | +164% | 2 M € |
| Balance sheet | |||||||||
| Equity | -2,2 M € | -109% | 23,8 M € | -6.0% | 25,3 M € | -5.7% | 26,9 M € | +23.7% | 21,7 M € |
| Total assets | 134,4 M € | -18.0% | 163,9 M € | -9.2% | 180,5 M € | +50.6% | 119,8 M € | +107% | 58 M € |
| Cash | 527,4 k € | -50.7% | 1,1 M € | -87.1% | 8,3 M € | +95.4% | 4,3 M € | +11.7% | 3,8 M € |
| Debts | 135,4 M € | -1.8% | 137,8 M € | -10.8% | 154,5 M € | +67.7% | 92,1 M € | +159% | 35,5 M € |
| Other | |||||||||
| Workforce | 349,0 ETP | +2.7% | 339,9 ETP | -2.9% | 350,0 ETP | -1.1% | 353,8 ETP | +11.3% | 318,0 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/03/20267 active · 11 ended
Active mandates
Ended mandates
Financials
Full financial information
Source · NBB| 2026 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Full model | Full model | Full model | Full model | Full model | Full model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/03/2026 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 15 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 06/07/2026 | 08/07/2025 | 17/07/2024 | 27/09/2023 | 26/07/2022 | 20/07/2021 |
| General meeting | 18/06/2026 | 12/06/2025 | 13/06/2024 | 25/09/2023 | 15/07/2022 | 10/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 27 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Full model | 31/03/2026 | 18/06/2026 | 06/07/2026 | Dutch | |
| Full model | 31/12/2024 | 12/06/2025 | 08/07/2025 | Dutch | |
| Consolidated accounts | 31/12/2024 | 12/06/2025 | 09/07/2025 | Dutch | |
| Full model | 31/12/2023 | 13/06/2024 | 17/07/2024 | Dutch | |
| Consolidated accounts | 31/12/2023 | — | 21/08/2024 | Dutch | |
| Full model | 31/12/2022 | 25/09/2023 | 27/09/2023 | Dutch | |
| Consolidated accountsCorrection | 31/12/2022 | 29/09/2023 | 19/07/2024 | Dutch | |
| Consolidated accounts | 31/12/2022 | 29/09/2023 | 29/09/2023 | Dutch | |
| Full model | 31/12/2021 | 15/07/2022 | 26/07/2022 | Dutch | |
| Full model | 31/12/2020 | 10/06/2021 | 20/07/2021 | Dutch | |
| Full model | 31/12/2019 | 14/05/2020 | 14/05/2020 | Dutch | |
| Full modelCorrection | 31/12/2018 | 09/05/2019 | 06/06/2019 | Dutch | |
| Full model | 31/12/2018 | 09/05/2019 | 14/05/2019 | Dutch | |
| Full model | 31/12/2017 | 11/05/2018 | 23/05/2018 | Dutch | |
| Full model | 31/12/2016 | 26/06/2017 | 18/07/2017 | Dutch | |
| Full model | 31/12/2015 | 23/05/2016 | 25/08/2016 | Dutch | |
| Full model | 31/12/2014 | 29/06/2015 | 30/06/2015 | Dutch | |
| Full model | 31/12/2013 | 18/06/2014 | 04/07/2014 | Dutch | |
| Full modelCorrection | 31/12/2012 | 19/07/2013 | 12/11/2013 | Dutch | |
| Full model | 31/12/2012 | 19/07/2013 | 25/07/2013 | Dutch | |
| Full model | 31/12/2011 | 25/06/2012 | 27/06/2012 | Dutch | |
| Full model | 31/12/2010 | 30/06/2011 | 01/07/2011 | Dutch | |
| Full model | 31/12/2009 | 14/06/2010 | 25/06/2010 | Dutch | |
| Full model | 31/12/2008 | 17/06/2009 | 26/06/2009 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 10 M€ and 25 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/03/20267 active · 11 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates04/06/2026STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING
- Other18/12/2025STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - ALGEMENE VERGADERING - BOEKJAAR
- Capital / shares30/10/2025STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - KAPITAAL - AANDELEN
- Mandates30/10/2025STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - ONTSLAGEN - BENOEMINGEN
- Mandates09/05/2025BENAMING - DIVERSEN - ONTSLAGEN - BENOEMINGEN
- Mandates01/07/2024ONTSLAGEN - BENOEMINGEN
- Mandates19/09/2023ONTSLAGEN - BENOEMINGEN
- Capital / shares05/09/2023STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - KAPITAAL - AANDELEN
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2026Annual accounts 2026-620,4 k €↑
- 16/10/2025nominationJonathan Wilson — bestuurder
- 16/10/2025nominationNadine Jakes — bestuurder
- 16/10/2025nominationTom Gibbs — bestuurder
- 16/10/2025reduction_capital
- 2024Annual accounts 2024-1,5 M €↑
- 30/12/2024nominationStichting Administratiekantoor Prothya Holding — niet-statutaire bestuurder
- 30/12/2024nominationProthya Biosolutions Netherlands B.V. — niet-statutaire bestuurder
- 06/05/2024nominationManja Hermina Elisabeth Maria Boerman — bestuurder
- 2023Annual accounts 2023-1,5 M €↓
- 04/09/2023nominationRoberto Carlos de Campos Morais — bestuurder
- 25/08/2023nominationJonathan Hahn — bestuurder
- 01/05/2023nominationRogier van den Braak — Sanquin Bestuurder
- 01/02/2023nominationSteven Skinner — Onafhankelijk Investeerder Bestuurder
- 2022Annual accounts 20225,2 M €↑
- 01/09/2022nominationRaf De Paepe — belast met het dagelijkse bestuur
- 15/07/2022nominationBDO Bedrijfsrevisoren BV — commissaris
- 15/07/2022nominationRodrigo Abels — vertegenwoordiger van de commissaris
- 01/01/2022demissionPieter de Geus — Sanquin Bestuurder
- 2021Annual accounts 20212 M €
- 24/12/1997IncorporationPrivate limited company